Compounding - Pharmacy Technician Pulse

Wicked Good Cardiometabolic Chat: Compounded Weight Loss Medications

Drug Topics

APRIL 29, 2025

In the first episode of the podcast, Jennifer Goldman and Hailey Choi discuss the latest FDA updates around compounded weight loss medications, clinical concerns and how pharmacists can protect their patients.

Compounding

Compounding FDA

Pharmacy Compounders Defend Semaglutide Compounding Amid Continued Shortages

Drug Topics

JUNE 15, 2023

Novo Nordisk is the only company with FDA-approved products containing semaglutide.

Compounding

Compounding FDA

Opinion: The FDA’s risky action on compounding weight loss drugs

STAT

NOVEMBER 19, 2024

Confronted with the public outcry, the FDA took an unusual step: It allowed pharmacies to continue making their own copies of the drug through the practice of pharmacy compounding, selling it at a fraction of Makena’s price.

Compounding

Compounding FDA

Examining Current Challenges in Parenteral Nutrition Compounding

Drug Topics

NOVEMBER 15, 2023

Compounding parenteral nutrition solutions is a complex process with a high risk for error, which can lead to serious adverse outcomes.

Compounding

STAT+: The end of compounded GLP-1 copies leaves many patients in a ‘lose-lose’ position

STAT

APRIL 29, 2025

The explosion of compounded GLP-1 offerings over the past two years is coming to an end, and many patients are left with no good options. Businesses are changing prescriptions, mixing in additives, or encouraging stockpiling of existing compounded products. Some have disappeared altogether.

Compounding

Compounding Compounding Pharmacies FDA

What is compounded semaglutide made of?

The Checkup by Singlecare

JANUARY 9, 2025

Due to the rising demand for weight loss drugs and the resulting drug shortages , some specialized compounding pharmacies make compounded semaglutide injections. Compounded versions of semaglutide contain varying ingredients, and theyre not approved by the U.S. There are a few times when compounding is necessary.

Compounding

Compounding Compounding Pharmacies FDA Sterile Compounds

FDA issues warnings to GLP-1 compounders

The Checkup by Singlecare

DECEMBER 19, 2024

As a result, the use of medications like Ozempic , Wegovy , Zepbound , Rybelsus , and Mounjaro has skyrocketed, as people turned to these medications to help them lose weightcausing drug shortages and creating a market for compounded versions of these brand-name drugs. RELATED: Is compounded semaglutide safe? But the U.S.

Compounding

Compounding FDA Labelling Compounding Pharmacies

Chronic Pain and Mental Health: A Compounding Relationship

Drug Topics

APRIL 15, 2024

In the United States, 12 million adults suffer from co-occurring chronic pain and anxiety or depression. Erasing stigmas, educating patients, and tailoring interventions can help to improve outcomes.

Compounding

STAT+: Court ruling opens door to FDA action against Ozempic compounders

STAT

APRIL 25, 2025

Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug semaglutide, sold under the brand names Ozempic and Wegovy. Compounding pharmacies are legally allowed to make versions of branded treatments if the drugs are deemed to be in shortage by the FDA.

Compounding

Compounding Compounding Pharmacies FDA

What to know before buying compounded semaglutide online

The Checkup by Singlecare

JANUARY 15, 2025

Compounded semaglutide is another option, and its lower cost may make it seem like an appealing alternative. Compounded drugs can feel like a reprieve from shortages, insurance denials, or high prices. Heres what you need to know before you buy compounded semaglutide online, according to experts. What are compounding pharmacies?

Compounding

Compounding Compounding Pharmacies FDA Dosage

Natural Compounds, Phytochemicals Have Potential to Treat Acute Pancreatitis

Drug Topics

DECEMBER 23, 2024

Researchers explored the impacts of natural bioactive compounds for the treatment of acute pancreatitis.

Compounding

The Importance of Continuing Education in Pharmacy Compounding

Drug Topics

DECEMBER 13, 2023

Kevin Hope, RPh, senior director of pharmacy education at Pharmcon, joined Drug Topics to discuss pharmacy compounding from the new USP changes and the importance of education around compounding best practices.

Compounding

STAT+: FDA confirms shortage of weight loss drug tirzepatide is over, gives compounders a grace period

STAT

DECEMBER 19, 2024

The agency said it would give these compounders a grace period of 60 to 90 days before enforcing rules that would put a halt to their work, in an effort to avoid disruption for patients.

Compounding

Compounding FDA Compounding Pharmacies

Novo Nordisk asks FDA to prevent compounders from making copycat versions of GLP-1 star semaglutide

Fierce Pharma

OCTOBER 23, 2024

The war is on between compounding pharmacies making knockoff versions of popular weight loss drugs and pharma giants Novo Nordisk and Eli Lilly, who want to protect their right to sell their patent | Novo Nordisk has asked the FDA to prevent compounders from manufacturing copycat versions of its juggernaut diabetes and obesity treatments Ozempic and (..)

Compounding

Compounding Compounding Pharmacies FDA

Majority of Online GLP-1 Advertising Misinformed Potential Consumers

Drug Topics

JANUARY 17, 2025

Researchers wanted to better understand the accuracy of advertising practices behind websites selling compounded GLP-1 RAs.

Compounding

With compounders out of the way, Lilly and Novo go after each other

PharmaVoice

MAY 5, 2025

The two obesity leaders are pulling on all levers to stay on top of the market.

Compounding

Judge rules against compounding group; Hims’ shares fall

STAT

MARCH 7, 2025

Today, we unpack Marty Makary’s Senate confirmation hearing, see a new ruling against GLP-1 compounders, examine the effects of the NIH patent freeze, and explore the tumultuous biotech job market. Sign up to get our biotech newsletter in your inbox. Read the rest…

Compounding

Pharmacists in California Stop Flavoring Medication for Children Due to New Rules

Drug Topics

NOVEMBER 30, 2023

Federal guidance from the United States Pharmacopeia characterizes the practice as drug compounding, which pharmacists fear may drive up prices.

Compounding

This is the end of GLP-1 compounding as we know it

STAT

APRIL 29, 2025

Good morning, we’ve got a bunch of news this morning about GLP-1 drugs, compounding, and biotechs’ interactions with the FDA. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Let’s get into it. Read the rest…

Compounding

Compounding FDA

Projection Estimates GLP-1 Market to Nearly Double by End of Decade | Asembia 2025

Drug Topics

MAY 1, 2025

Although the market is expected to continue to become more popular, compounding pharmacies will no longer be allowed to manufacture these medications, as shortages have been listed as resolved.

Compounding Pharmacies

Compounding Pharmacies Compounding

What Does an Oncology Pharmacy Technician Do?

Drug Topics

APRIL 20, 2023

From compounding to cleaning, oncology pharmacy technicians take on key responsibilities in infusion centers.

Compounding

Coffee May Be Unexpected Protectant Against COVID-19 Infection

Drug Topics

NOVEMBER 20, 2023

Rich in polyphenolic compounds like chlorogenic acid (CGA), coffee may help ward off COVID-19 infection in the post-pandemic era.

Compounding

Compounded semaglutide side effects

The Checkup by Singlecare

FEBRUARY 17, 2025

Many people are turning to compounded versions of semaglutide for various reasons, such as costs and shortages of approved medications like Ozempic and Wegovy. While compounding alternatives might seem appealing, they lack the testing and quality control of their approved counterparts. Is compounded semaglutide safe?

Compounding

Compounding Compounding Pharmacies FDA Dosage

Should Pharmacies Keep Compounding GLP1s?

DiversifyRx

APRIL 29, 2025

Should You Keep Compounding GLP1s (Tirzepatide or Semaglutide) After the FDA Deadline? Howdy pharmacy peeps… Lets have a real talk about compounding GLP1s. These compounds have been huge revenue drivers and powerful tools for helping patients lose weight and improve metabolic health. Here’s My Take. But others?

Compounding

Compounding Sterile Compounds FDA Compounding Pharmacies

Opinion: How to stop the shift of drug discovery from the U.S. to China

STAT

MAY 6, 2025

By 2024, one-third of their new compounds were coming from Chinese biotechnology firms. As in many other industries, it’s so much cheaper to synthesize new compounds inside Chinese biotechnology firms once a novel biological target has been discovered in American laboratories. Five years ago, U.S. Why are U.S.

Compounding

Compounding Pharmaceutical Companies Pharmaceutical Companies FDA

STAT+: Pharmalittle: We’re reading about Zepbound price and dose changes, compounders suing FDA, and more

STAT

FEBRUARY 25, 2025

… Eli Lilly will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the company seeks to draw patients away from cheap, compounded copies of weight loss medications , STAT reports. Pharmacy compounders sued the U.S. Continue to STAT+ to read the full story…

Compounding

Compounding FDA Compounding Pharmacies Communication

Why Safety is Crucial in Hazardous Drug Compounding

Drug Topics

DECEMBER 6, 2023

A Q&A with Lisa McCabe, PharmD, MBA, BSN, director of Health System Pharmacy at Cardinal Health.

Compounding

Pharmaceutical Compounding, Storage of Faricimab Preserves Stability, Binding Properties

Drug Topics

NOVEMBER 28, 2023

Maintaining the structure and function of antibody biologics like faricimab is critical for their administration via intravitreal injection (IVI), a common treatment approach for retinal diseases.

Compounding

Compounded semaglutide with B12: Benefits and risks

The Checkup by Singlecare

MARCH 31, 2025

However, due to the shortage, compounding pharmacies and facilities were allowed to temporarily produce compounded semaglutide to meet the high demandeven though compounded semaglutide injections are not FDA approved. Some facilities add B12 to their compounds, in addition to semaglutide.

Compounding

Compounding Compounding Pharmacies FDA Adverse Reactions

Advancing Compounding Standards: Insights From the USP Compounding Implementation Workshop

Pharmacy Times

NOVEMBER 21, 2024

The workshop addressed trends, initiatives, and regulations for quality compounding.

Compounding

Compounding Pharmacies Market Caters To Key Regional Health Care Issues

Pharmacy Times

JULY 18, 2022

Pharmacists can leverage patient medical history for formulating effective drugs, and patients can also benefit from single dosage, greater efficacy, and affordability of compounded medications.

Compounding

Compounding Compounding Pharmacies Dosage

STAT+: Novo asks FDA to bar compounders from making Ozempic copies

STAT

OCTOBER 22, 2024

Novo Nordisk has asked the Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex for the pharmacies to safely make. The FDA still has to make a decision on whether to officially place semaglutide on the lists.

Compounding

Compounding Compounding Pharmacies FDA Documentation

GLP-1 compounding is still in limbo. Will the FDA leave it for the next administration?

PharmaVoice

DECEMBER 11, 2024

The agency has yet to make a decision about keeping tirzepatide on or off of its shortage list — letting compound pharmacies continue their lucrative operations for now.

Compounding

Compounding Compounding Pharmacies FDA

Paediatric oral compounding: expert insights from a global study

Hospital Pharmacy Europe

JANUARY 16, 2025

A new global study from the International Pharmaceutical Federation (FIP)s Pediatric Formulations Focus Group is the first to report current and global paediatric oral extemporaneous compounding practices. The FIP study aimed to identify current global paediatric oral extemporaneous compounding practices, challenges and needs.

Compounding

Compounding Labelling Dosage Hospitals

STAT+: Novo Nordisk’s Ozempic and Wegovy, long in shortage, are now listed as available by FDA

STAT

OCTOBER 30, 2024

Over the past two years, patients seeking treatment have been turning to compounding pharmacies, which make cheaper copies of branded treatments and are legally allowed to do so only when the branded treatments are listed on the FDA’s shortage list.

Compounding Pharmacies

Compounding Pharmacies FDA Compounding

FDA Affirms Decision on Tirzepatide Shortage Resolved, Sets Transition Period for Compounding

Pharmacy Times

DECEMBER 20, 2024

Compounding pharmacies have a 60- to 90-day grace period to complete production as it continues to monitor supply and demand.

Compounding

Compounding Compounding Pharmacies FDA

Psychedelic Therapeutics: Education, Advocacy Key to Overcoming Integration Hurdles

Drug Topics

MARCH 26, 2024

According to Sa’ed Al-Olimat, education and advocacy are key to ensure a safe and accessible landscape of psychedelic therapeutics, especially as the compounds inch closer to the mainstream health care market.

Compounding

Preserving Patient Access to Compounded Medications Act of 2017

Pharmacy Times

SEPTEMBER 14, 2023

The act would have permitted health care facilities to stock up on compounded medications without forcing the supplying 503A pharmacies to register as outsourcing facilities.

Compounding

ASHP Midyear: Technology Helps Leverage Medication Management, IV Compounding

Pharmacy Times

DECEMBER 10, 2024

Pharmacists are essential members of the patient care team, leveraging technology like automated IV compounding to standardize processes.

Compounding

Compounding Patient Care

Novo Nordisk Calls for FDA to Prohibit Compounding Pharmacies from Providing Semaglutide

Pharmacy Times

OCTOBER 25, 2024

The call follows the FDA’s sudden removal of tirzepatide from the drug shortage list, preventing compounding pharmacies from providing the drug.

Compounding Pharmacies

Compounding Pharmacies Compounding FDA

Compounders sue FDA for removing Eli Lilly's tirzepatide from shortage list

Fierce Pharma

OCTOBER 8, 2024

With an estimated 2 million people in the United States taking copycat vers | A compounding industry group has sued the FDA, claiming its action to remove Eli Lilly’s Mounjaro and Zepbound from its drug shortage list is a “reckless and arbitrary decision—lacking any semblance of lawful process.”

Compounding

Compounding Compounding Pharmacies FDA

AI company zeros in on compounds to treat addiction by rewiring the brain

PharmaVoice

DECEMBER 5, 2022

GATC Health is driving a novel approach it believes could work for several major neurological conditions.

Compounding

Are Compounding Pharmacies Safe? Everything You Need to Know

Compounding Pharmacy of America

DECEMBER 23, 2024

Learn how compounding pharmacies ensure safety and reliability through rigorous standards, sterile preparations, and personalized solutions for unique healthcare needs. The post Are Compounding Pharmacies Safe? Everything You Need to Know appeared first on Compounding Pharmacy of America.

Compounding Pharmacies

Compounding Pharmacies Compounding

Will compounded semaglutide be banned?

The Checkup by Singlecare

JANUARY 13, 2025

A compounded medication is a custom formulation of an existing brand-name or generic drug made by a licensed pharmacist and designed to meet a patients unique needs. For example, a person who is allergic to a common dye included in a prescription drug could have a compounded version of the drug made without that dye.

Compounding

Compounding Compounding Pharmacies FDA Insurance Coverage

Wicked Good Cardiometabolic Chat: Compounded Weight Loss Medications

Pharmacy Compounders Defend Semaglutide Compounding Amid Continued Shortages

Trending Sources

Opinion: The FDA’s risky action on compounding weight loss drugs

Examining Current Challenges in Parenteral Nutrition Compounding

STAT+: The end of compounded GLP-1 copies leaves many patients in a ‘lose-lose’ position

What is compounded semaglutide made of?

FDA issues warnings to GLP-1 compounders

Chronic Pain and Mental Health: A Compounding Relationship

STAT+: Court ruling opens door to FDA action against Ozempic compounders

What to know before buying compounded semaglutide online

Natural Compounds, Phytochemicals Have Potential to Treat Acute Pancreatitis

The Importance of Continuing Education in Pharmacy Compounding

STAT+: FDA confirms shortage of weight loss drug tirzepatide is over, gives compounders a grace period

Novo Nordisk asks FDA to prevent compounders from making copycat versions of GLP-1 star semaglutide

Majority of Online GLP-1 Advertising Misinformed Potential Consumers

With compounders out of the way, Lilly and Novo go after each other

Judge rules against compounding group; Hims’ shares fall

Pharmacists in California Stop Flavoring Medication for Children Due to New Rules

This is the end of GLP-1 compounding as we know it

Projection Estimates GLP-1 Market to Nearly Double by End of Decade | Asembia 2025

What Does an Oncology Pharmacy Technician Do?

Coffee May Be Unexpected Protectant Against COVID-19 Infection

Compounded semaglutide side effects

Should Pharmacies Keep Compounding GLP1s?

Opinion: How to stop the shift of drug discovery from the U.S. to China

STAT+: Pharmalittle: We’re reading about Zepbound price and dose changes, compounders suing FDA, and more

Why Safety is Crucial in Hazardous Drug Compounding

Pharmaceutical Compounding, Storage of Faricimab Preserves Stability, Binding Properties

Compounded semaglutide with B12: Benefits and risks

Advancing Compounding Standards: Insights From the USP Compounding Implementation Workshop

Compounding Pharmacies Market Caters To Key Regional Health Care Issues

STAT+: Novo asks FDA to bar compounders from making Ozempic copies

GLP-1 compounding is still in limbo. Will the FDA leave it for the next administration?

Paediatric oral compounding: expert insights from a global study

STAT+: Novo Nordisk’s Ozempic and Wegovy, long in shortage, are now listed as available by FDA

FDA Affirms Decision on Tirzepatide Shortage Resolved, Sets Transition Period for Compounding

Psychedelic Therapeutics: Education, Advocacy Key to Overcoming Integration Hurdles

Preserving Patient Access to Compounded Medications Act of 2017

ASHP Midyear: Technology Helps Leverage Medication Management, IV Compounding

Novo Nordisk Calls for FDA to Prohibit Compounding Pharmacies from Providing Semaglutide

Compounders sue FDA for removing Eli Lilly's tirzepatide from shortage list

AI company zeros in on compounds to treat addiction by rewiring the brain

Are Compounding Pharmacies Safe? Everything You Need to Know

Will compounded semaglutide be banned?

Stay Connected